Drug Commercials Aren’t Just Annoying — They’re Costing You Money
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
As corporate pharmacy middlemen slash reimbursement fees to independent drugstores, local Illinois pharmacists push for legislative change.
Plus, free tax filing pays off, electric vehicles work double time, and pharmaceutical giants face scrutiny for outrageous pricing.
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.